Obstructive Sleep Apnea Clinical Trial
— PEERS-EDOfficial title:
Tailored Peer-Based Sleep Health Education and Social Support Among Blacks With Obstructive Sleep Apnea
Reducing sleep health disparities was recognized as a priority area for intervention by the National Institutes of Health. Sleep apnea, which disproportionately affects minorities, is an important preventable and treatable disease that should be targeted as it is associated with increased cardiovascular risk and disease outcomes, including obesity, diabetes, hypertension, stroke, cardiac arrhythmia, and chronic heart failure. Evidence from previous research suggests that most minorities are unaware of general sleep problems, such as sleep apnea symptoms and the negative effects on cardiovascular disease. Only 26% of minorities participating in the investigators prior research followed up on recommended sleep apnea screening, although 39% were at high risk for sleep apnea. While few followed the physician's recommendations, 90% of those assessed received a sleep apnea diagnosis. The investigators research will assess the effectiveness of peer-based sleep health education and social support in increasing sleep apnea screening and treatment rates among minorities with sleep apnea risk. Participants will receive quality-controlled and culturally tailored peer education using a sleep health education manual. They will each receive up to 4 sessions promoting sleep apnea screening during a 6-month period. Those with a diagnosis will receive 2 additional sessions promoting sleep apnea treatment adherence, in conjunction with telephone interventions. The investigators research will also assess the rate of sleep apnea among minorities using home recordings. The long-term goal of the investigators study is to apply this intervention in community-based settings (barbershops, beauty salons, churches, and health centers), thereby linking community health promotion to the healthcare system.
Status | Recruiting |
Enrollment | 398 |
Est. completion date | May 2019 |
Est. primary completion date | May 2019 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - self-reported race/ethnicity as black - ages =18 years - accessible by telephone - no plans to move away from the region within the year following enrollment - consent to participate, which includes permission to release medical record information - A positive screening for OSA is necessary to be enrolled in the intervention protocol. Exclusion Criteria: - are involved in another sleep study. - are unable to understand and sign this informed consent form. - know someone who is participating in this study. - plan to move away in the next two years. - had a heart attack or stroke within the past 12 weeks. - do not identify yourself as Black or African American. - are pregnant. - are not at risk for sleep apnea. - refuse to use the Apnea Risk Evaluation System (ARES) home sleep test device. |
Country | Name | City | State |
---|---|---|---|
United States | NYULMC Department of Population Health - Center for Healthful Behavior Change | New York | New York |
Lead Sponsor | Collaborator |
---|---|
Dr. Girardin Jean-Louis | New York University School of Medicine |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Number of participants to adhere to CPAP treatment | Following recommended treatment of CPAP machine. | 0-12 months | |
Primary | Number of participants to complete home study | In this phase the successful completion of a 7 day sleep home study. | 0-12 months | |
Secondary | Number of participants to complete a sleep clinic test | Participants complete an overnight clinical sleep test for diagnosing obstructive sleep apnea as well as customizing of continuous positive airway treatment. | 0-12 months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05857384 -
Bioavailability, Bioequivalence and Tolerability of IHL-42X Compared to the Reference Drugs
|
Phase 1 | |
Recruiting |
NCT04547543 -
Follow-up of Apneic Patients by Visio-consultation
|
N/A | |
Recruiting |
NCT05371509 -
Novel Myofunctional Water Bottle to Reduce OSA and Snoring Study
|
N/A | |
Completed |
NCT02515357 -
Mediterranean Diet/Lifestyle Intervention in Obstructive Sleep Apnea
|
N/A | |
Completed |
NCT05582070 -
Effect on Sleep of Surgical Treatment of Severe Nasal Obstruction
|
N/A | |
Active, not recruiting |
NCT03189173 -
Combined Upper-airway and Breathing Control Therapies for Obstructive Sleep Apnea
|
Phase 2 | |
Completed |
NCT04084899 -
The Effect of CPAP on Lung Hyperinflation in Patients With OSA
|
||
Completed |
NCT03032029 -
Registry on the Treatment of Central and Complex Sleep-Disordered Breathing With Adaptive Servo-Ventilation
|
||
Recruiting |
NCT04028011 -
Clinical Evaluation of a Wearable Technology for the Diagnosis of Sleep Apnoea
|
||
Recruiting |
NCT06047353 -
Community Health Advocates for Motivating PAP Use in Our Neighborhoods.
|
N/A | |
Completed |
NCT05253963 -
Acute Effect of CPAP on Weight in Patients With Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT06029959 -
Stroke and CPAP Outcome Study 3
|
N/A | |
Recruiting |
NCT06150352 -
Sleep Apnea, Neurocognitive Decline and Brain Imaging in Patients With Subjective or Mild Cognitive Impairment
|
||
Completed |
NCT03589417 -
Postural Stability, Balance and Fall Risk in Patients With Obstructive Sleep Apnea
|
||
Recruiting |
NCT04335994 -
ENhancing Outcomes in Cognitive Impairment Through Use of Home Sleep ApNea Testing
|
N/A | |
Withdrawn |
NCT04063436 -
Evaluation of a New Nasal Pillows Mask for the Treatment of Obstructive Sleep Apnea
|
N/A | |
Recruiting |
NCT05385302 -
Sociological Determinants of Positive Airway Pressure Adherence in OSA Patients
|
||
Recruiting |
NCT04572269 -
Metabolomics of Obstructive Sleep Apnea
|
||
Not yet recruiting |
NCT06467682 -
12-week Tele-exercise Program in Patients With OSA
|
N/A | |
Withdrawn |
NCT04011358 -
Retinal Vein Occlusion and Obstructive Sleep Apnea: A Case Control Study
|
N/A |